Results 201 to 210 of about 125,979 (217)
Safety of synthetic cannabidiol as a novel food pursuant to regulation (EU) 2015/2283
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on cannabidiol (CBD) obtained by chemical synthesis as a novel food (NF) pursuant to Regulation (EU) 2015/2283.
EFSA Panel on Nutrition +26 more
wiley +1 more source
Episodic ataxia in CASPR2 autoimmunity. [PDF]
López Chiriboga AS, Pittock S.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity
International Journal of Molecular Sciences, 2020Edward Glasscock, Lauren A McCormick
exaly
Genetic paroxysmal neurological disorders featuring episodic ataxia and epilepsy
European Journal of Medical Genetics, 2022Angelo Russo +2 more
exaly
Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins
Neurology, 2010Dimitri Kullmann +2 more
exaly
Episodic ataxia associated with a de novo SCN2A mutation
European Journal of Paediatric Neurology, 2016Maja Tarailo-Graovac +2 more
exaly
Acetazolamide improves neurotological abnormalities in a family with episodic ataxia type 2 (EA-2)
Journal of Neurology, 2004Hanna Harno +2 more
exaly

